ז'בלור

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

VINFLUNINE DITARTRATE

MAH:

PERRIGO ISRAEL AGENCIES LTD

ATC_code:

L01CA05

pharmaceutical_form:

תרכיז להכנת תמיסה לאינפוזיה

composition:

VINFLUNINE DITARTRATE 25 MG/ML

administration_route:

תוך-ורידי

prescription_type:

מרשם נדרש

manufactured_by:

PIERRE FABRE MEDICAMENT PRODUCTION, FRANCE

therapeutic_group:

VINFLUNINE

therapeutic_area:

VINFLUNINE

therapeutic_indication:

Javlor is indicated in monotherapy for the treatment of adult patients with advanced or metastatic transitional cell carcinoma of the urothelial tract after failure of a prior platinium-containing regimen. Efficacy and safety of vinflunine have not been studied in patients with Performance Status ?2.

authorization_date:

2017-08-31